These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 22769598)

  • 1. Survival benefit of increasing colorectal cancer screening uptake in Wolverhampton, UK: an exploratory study.
    Anand V; Gwinnett J; Phillips A
    Public Health; 2012 Sep; 126 Suppl 1():S44-S46. PubMed ID: 22769598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of the faecal immunochemical test at a range of positivity thresholds compared with the guaiac faecal occult blood test in the NHS Bowel Cancer Screening Programme in England.
    Murphy J; Halloran S; Gray A
    BMJ Open; 2017 Oct; 7(10):e017186. PubMed ID: 29079605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downstaging of colorectal cancer by the National Bowel Cancer Screening programme in England: first round data from the first centre.
    Ellul P; Fogden E; Simpson CL; Nickerson CL; McKaig BC; Swarbrick ET; Veitch AM
    Colorectal Dis; 2010 May; 12(5):420-2. PubMed ID: 19843116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of population-based faecal occult blood test screening upon emergency colorectal cancer admissions in Coventry and north Warwickshire.
    Goodyear SJ; Leung E; Menon A; Pedamallu S; Williams N; Wong LS
    Gut; 2008 Feb; 57(2):218-22. PubMed ID: 18048571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer.
    Hardcastle JD; Chamberlain JO; Robinson MH; Moss SM; Amar SS; Balfour TW; James PD; Mangham CM
    Lancet; 1996 Nov; 348(9040):1472-7. PubMed ID: 8942775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost effectiveness of CT colonography for UK NHS colorectal cancer screening of asymptomatic adults aged 60-69 years.
    Lee D; Muston D; Sweet A; Cunningham C; Slater A; Lock K
    Appl Health Econ Health Policy; 2010; 8(3):141-54. PubMed ID: 20369905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethnic variation in colorectal cancer risk following a positive faecal occult blood test in an English bowel cancer screening programme centre.
    Padmanabhan H; Widlak M; Nevill A; McKaig B; Brookes M; Veitch A
    Eur J Gastroenterol Hepatol; 2015 Nov; 27(11):1281-5. PubMed ID: 26267240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of CT colonography for colorectal cancer screening on the UK NHS: costs, healthcare resources and health outcomes.
    Sweet A; Lee D; Gairy K; Phiri D; Reason T; Lock K
    Appl Health Econ Health Policy; 2011; 9(1):51-64. PubMed ID: 21174482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NHS Bowel Cancer Screening Programme--a realistic approach with additional benefits.
    West NJ; Poullis AP; Leicester RJ
    Colorectal Dis; 2008 Sep; 10(7):708-14. PubMed ID: 17956587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up.
    Scholefield JH; Moss SM; Mangham CM; Whynes DK; Hardcastle JD
    Gut; 2012 Jul; 61(7):1036-40. PubMed ID: 22052062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Likely effect of adding flexible sigmoidoscopy to the English NHS Bowel Cancer Screening Programme: impact on colorectal cancer cases and deaths.
    Geurts SM; Massat NJ; Duffy SW
    Br J Cancer; 2015 Jun; 113(1):142-9. PubMed ID: 26110973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Planning for a possible national colorectal cancer screening programme.
    Garvican L
    J Med Screen; 1998; 5(4):187-94. PubMed ID: 9934649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting the impact of the screening programme for colorectal cancer in the UK.
    Parkin DM; Tappenden P; Olsen AH; Patnick J; Sasieni P
    J Med Screen; 2008; 15(4):163-74. PubMed ID: 19106256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds.
    Kronborg O; Jørgensen OD; Fenger C; Rasmussen M
    Scand J Gastroenterol; 2004 Sep; 39(9):846-51. PubMed ID: 15513382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Slipping through the bowel cancer screening programme.
    Hallifax R; Lacey M; Bevis P; Borley NR; Brooklyn T; Wheeler JM
    Colorectal Dis; 2012 Jul; 14(7):844-7. PubMed ID: 21920009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inappropriate use of the faecal occult blood test outside of the National Health Service colorectal cancer screening programme.
    Peacock O; Watts ES; Hanna N; Kerr K; Goddard AF; Lund JN
    Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1270-5. PubMed ID: 22872076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised study of screening for colorectal cancer with faecal-occult-blood test.
    Kronborg O; Fenger C; Olsen J; Jørgensen OD; Søndergaard O
    Lancet; 1996 Nov; 348(9040):1467-71. PubMed ID: 8942774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of research questionnaires in the NHS Bowel Cancer Screening Programme in England: impact on screening uptake.
    Watson J; Shaw K; Macgregor M; Smith S; Halloran S; Patnick J; Beral V; Green J;
    J Med Screen; 2013 Dec; 20(4):192-7. PubMed ID: 24177175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal cancer screening using the faecal occult blood test (FOBt): a survey of GP attitudes and practices in the UK.
    Damery S; Clifford S; Wilson S
    BMC Fam Pract; 2010 Mar; 11():20. PubMed ID: 20214769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Colorectal cancer screening: advice from the Health Council of the Netherlands].
    van Veen W; Mali WP
    Ned Tijdschr Geneeskd; 2009; 153():A1441. PubMed ID: 20003552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.